Accès ouvert déclaré2021preprint
Seroprevalence of anti-SARS-CoV-2 IgG antibodies among truck drivers and assistants in Kenya
E. Wangeci Kagucia, John N. Gitonga, Catherine Kalu, Eric Ochomo, Benard Ochieng, Nickline Kuya, Angela Karani, James Nyagwange, Boniface Karia, Daisy Mugo, Henry Karanja, James Tuju, Agnes Mutiso, Hosea Maroko, Lucy Okubi, Eric K. Maitha, Hossan Ajuck, Mary Bogita, Richmond Mudindi, David Mukabi, Wycliffe Moracha, David Bulimu, Nelson Andanje, Evans Shiraku, Rosemary Okuku, Monicah Ogutu, Rashid Aman, Mercy Mwangangi, Patrick Amoth, Kadondi Kasera, Wangari Ng’ang’a, Rodgers Mariga, Tobias Munabi, Susan M Ramadhan, Janet Mwikali, Rose Nasike, Cornelius Andera, Roselyne Nechesa, Benson K Kiplagat, Julius Omengo, Simon Oteba, Arthur Mwangi, Dorcas Mkanyi, George Karisa, Judith K Migosi, Patrick Msili, Samson Mwambire, Anthony Makenga Boniface, Amek Nyaguara, Shirine Voller, Mark Otiende, Christian Bottomley, Charles N. Agoti, Lynette Isabella Ochola‐Oyier, Ifedayo Adetifa, Anthony Etyang, Katherine E. Gallagher, Sophie Uyoga, Edwine Barasa, Philip Bejon, Benjamin Tsofa, Ambrose Agweyu, George M. Warimwe, J. Anthony G. Scott
16Citations signalées
7Institutions associées
2Pays d’affiliation
Résumé fourni par la source
Abstract In October 2020, anti-SARS-CoV-2 IgG seroprevalence among truck drivers and their assistants (TDA) in Kenya was 42.3%, higher than among other key populations. TDA transport essential supplies during the COVID-19 pandemic, placing them at increased risk of being infected and of transmitting SARS-CoV-2 infection over a wide geographical area.
Sujets associés
SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesVaccine Coverage and Hesitancy